Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
7-{[(Cyclohexylamino)carbonyl]amino}heptanoic acid is a synthetic small molecule belonging to the class of medium-chain fatty acids, specifically a heptanoic acid derivative with a cyclohexylureido group. It has been studied primarily as an experimental compound and is known to act as an inhibitor of bifunctional epoxide hydrolase 2 (also known as soluble epoxide hydrolase, sEH), an enzyme involved in the metabolism of endogenous lipid signaling molecules. By inhibiting this enzyme, the compound may modulate levels of bioactive lipids implicated in inflammation and cardiovascular regulation. Its primary use has been in biochemical research rather than clinical medicine[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7-{[(cyclohexylamino)carbonyl]amino}heptanoic acid.